SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-286156
Filing Date
2021-09-29
Accepted
2021-09-29 08:42:33
Documents
13
Period of Report
2021-09-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d217857d8k.htm   iXBRL 8-K 24601
2 EX-99.1 d217857dex991.htm EX-99.1 15885
  Complete submission text file 0001193125-21-286156.txt   172230

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alna-20210929.xsd EX-101.SCH 2903
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20210929_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20210929_pre.xml EX-101.PRE 11867
6 EXTRACTED XBRL INSTANCE DOCUMENT d217857d8k_htm.xml XML 3483
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 211289520
SIC: 2836 Biological Products, (No Diagnostic Substances)